Articles
DOI DOI: 10.62441/actainnovations.vi.3010

INVESTIGATION INTO THE THERAPEUTIC POTENTIAL OF THOTTEA SILIQUOSA EXTRACT IN AMELIORATING INFLAMMATORY MEDIATORS AND ANTIARTHRITIC POTENTIAL: A PRECLINICAL IN VITRO AND IN VIVO APPROACH

Abstract

Thottea siliquosa has been traditionally used to treat various inflammatory conditions. In the present study, an attempt has been made to evaluate the anti-arthritic activity of aqueous alcoholic extract of Thottea siliquosa through in vitro and in vivo procedures, including proteinase inhibitory activity, egg albumin denaturation assay, nitric oxide (NO) inhibition assay, and assessment of inflammatory mediators like TNF-α,  IL-6, and  IL-1β. In in vivo study, Thottea siliquosa  (200 and 400 mk/kg) was evaluated using carrageenan-inducedarthritic models.  In in vitro Thottea siliquosa has shown dose-dependent proteinase inhibitory activity, and egg albumin denaturation, and anti-inflammatory activity through the reduction on NO, and pro-inflammatory mediators like TNF-α, IL-6, and IL-1β. In in vivo Thottea siliquosa significantly inhibited increase in paw and joint swelling as compared to diseased group. In addition it has shown to improve body weight, muscle strength using Kondziela's inverted screen test, and increased thermal response latency.It is thus possible that Thottea siliquosa may be a possible candidate for anti-arthriticdrugs. Further, the molecular level and genetic studies are required to confirm its exact mechanism of action.

 

How to Cite

D, D., Yaduvanshi, D. P. S., Loksh, D. K., & Sharma, D. S. (2026). INVESTIGATION INTO THE THERAPEUTIC POTENTIAL OF THOTTEA SILIQUOSA EXTRACT IN AMELIORATING INFLAMMATORY MEDIATORS AND ANTIARTHRITIC POTENTIAL: A PRECLINICAL IN VITRO AND IN VIVO APPROACH. ACTA INNOVATIONS, 246–258. https://doi.org/10.62441/actainnovations.vi.3010

References

  1. 1. Brown P, Pratt AG, Hyrich KL. Therapeutic advances in rheumatoid arthritis. BMJ. 2024;384:e070856. doi:10.1136/bmj-2022-070856.
  2. 2. Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022;18:591-602.
  3. 3. Zhang F, Wei K, Slowikowski K, Fonseka CY, Rao DA, Kelly S, et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature. 2023;623:616-624.
  4. 4. Sharma A, Goel A. Pathogenesis of rheumatoid arthritis and its treatment with anti-inflammatory natural product. Mol Biol Rep. 2023;50:4687–4706.
  5. 5. Rathinam MM, Elakkiya. Targeting CD4/6 in cancer: molecular docking and cytotoxic evaluation of Thottea siliquosa root extract. Biomedicines. 2025;13(7):1658. doi:10.3390/biomedicines13071658.
  6. 6. Renny A, et al. Biogenic silver nanoparticles from Thottea siliquosa: synthesis, characterization, and evaluation of antioxidant, anti-inflammatory, anticancer, and antibacterial activities. Biocatal Agric Biotechnol. 2025; doi:10.1016/j.bcab.2025.103710.
  7. 7. Dibinlal D. Ethnopharmacological relevance of Apama siliquosa: phytochemistry and emerging pharmacological evidence. J Anim Environ. 2026;18(2):21. doi:10.70102/AEJ.2026.18.2.21.
  8. 8. Aslam I, Yasmeen R. Vertebrate diversity at Margalla Hills National Park, Pakistan. Arxius de Miscellània Zoològica. 2021;19:237–247.
  9. 9. HDT M. In vitro anti-inflammatory egg albumin denaturation assay: an enhanced approach. J Nat Ayurvedic Med. 2023;7(3):1–6.
  10. 10. Chandra S, Chatterjee P, Dey P, Bhattacharya S. Evaluation of in vitro anti-inflammatory activity of coffee against the denaturation of protein. Asian Pac J Trop Biomed. 2012;2(1):S178–S180.
  11. 11. Azmir J, Zaidul ISM, Rahman MM, Sharif KM, Mohamed A, Sahena F, et al. Techniques for extraction of bioactive compounds from plant materials: a review. J Food Eng. 2013;117(4):426–436.
  12. 12. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63.
  13. 13. Goel N, et al. A comparative assessment of in vitro cytotoxic activity and phytochemical profiling of Andrographis nallamalayana JL Ellis and Andrographis paniculata (Burm. f.) Nees using UPLC-QTOF-MS/MS approach. RSC Adv. 2021;11(57):35918-36.
  14. 14. Biswas A,et al., In vitro cytotoxicity testing of novel drug molecules using MTT assay. Int J Pharm Res Appl. 2025;10(2):1603-11.
  15. 15. Choudhary R, Kumar P, Shukla SK, Bhagat A, Anal JMH, Kour G, Ahmed Z. Synthesis and potential anti-inflammatory response of indole and amide derivatives of ursolic acid in LPS-induced RAW 264.7 cells and systemic inflammation mice model: insights into iNOS, COX-2 and NF-κB. Bioorg Chem. 2025;155:108091.
  16. 16. Francis DL,et al., Preclinical Safety Assessment of an Ayurvedic Dentifrice: Acute and 28‐Day Oral Toxicity Studies in Wistar Albino Rats. Journal of Toxicology. 2025;2025(1):1379571
  17. 17. Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 1997 Oct 3;61(19):1861-78.
  18. 18. Brand DD, Kang AH, Rosloniec EF. The mouse model of collagen-induced arthritis. In: Autoimmunity: methods and protocols. Totowa (NJ): Humana Press; 2004. p. 295-312.
  19. 19. Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc. 2007;2(5):1269-75. doi:10.1038/nprot.2007.173.
  20. 20. Song HP, Li X, Yu R, Zeng G, Yuan ZY, Wang W, et al. Phenotypic characterization of type II collagen-induced arthritis in Wistar rats. Exp Ther Med. 2015 Oct;10(4):1483-8. doi:10.3892/etm.2015.2667. Epub 2015 Jul 31.
  21. 21. Bolon B, Stolina M, King C, Middleton S, Gasser J, Zack D, et al. Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. Biomed Res Int. 2011;2011:569068. doi:10.1155/2011/569068.
  22. 22. Kaihara K, Nakagawa S, Arai Y, Inoue H, Tsuchida S, Fujii Y, et al. Sustained hypoxia suppresses joint destruction in a rat model of rheumatoid arthritis via negative feedback of hypoxia-inducible factor-1α. Int J Mol Sci. 2021;22(8):3898. doi:10.3390/ijms22083898.
  23. 23. Shejawal N, Menon S, Shailajan S. A simple, sensitive and accurate method for rat paw volume measurement and its expediency in preclinical animal studies. Hum Exp Toxicol. 2014;33(2):123-9. doi:10.1177/0960327113482594.
  24. 24. Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. doi:10.1371/journal.pbio.3000410.
  25. 25. Deacon RMJ. Measuring the strength of mice. J Vis Exp. 2013;(76):e2610. doi:10.3791/2610.
  26. 26. AlSabagh AT, Rao MS, Renno WM. The impact of heat therapy on neuromuscular function and muscle atrophy in diabetic rats. Front Physiol. 2022;13:1039588. doi:10.3389/fphys.2022.1039588.
  27. 27. Eddy NB, Leimbach D. Synthetic analgesics. II. Dithienyl butenyl- and dithienyl butylamines. J Pharmacol Exp Ther. 1953;107(3):385-393.
  28. 28. Deuis JR, Dvorakova LS, Vetter I. Methods used to evaluate pain behaviors in rodents. Front Mol Neurosci. 2017;10:284. doi:10.3389/fnmol.2017.00284.
  29. 29. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev. 2001;53(4):597-652.
  30. 30. Gul S, Akbar A, Leghari M. Elucidating therapeutic and biological potential of Berberis baluchistanica Ahrendt bark, leaf, and root extracts. Front Microbiol. 2022;13:823673. doi:10.3389/fmicb.2022.823673.
  31. 31. Mao N, Yu Y, Lu X, Yang Y. Preventive effects of matrine on LPS-induced inflammation in RAW 264.7 cells and intestinal damage in mice through the TLR4/NF-κB/MAPK pathway. Int Immunopharmacol. 2024. doi:10.1016/j.intimp.2024.113432.
  32. 32. Kang JK, Hyun CG. 4-Hydroxy-7-methoxycoumarin inhibits inflammation in LPS-activated RAW264.7 macrophages by suppressing NF-κB and MAPK activation. Molecules. 2020 Sep 26;25(19):4424. doi:10.3390/molecules25194424.
  33. 33. Steigerova M, Sima M, Slanar O. Pathogenesis of collagen-induced arthritis: role of immune cells with associated cytokines and antibodies, comparison with rheumatoid arthritis. Folia Biol (Praha). 2023;69(2):41-49. doi:10.14712/fb2023069020041.
  34. 34. Babaahmadi M, Gholipour NM, Tayebi B, Pheneger J, Hajizadeh-Saffar E, Eslaminejad MB, et al. Clinical evaluation of collagen-induced arthritis in female Lewis rats: a comprehensive analysis of disease progression and severity. Cell J. 2023;25(12):854-862. doi:10.22074/cellj.2023.2004504.1326.
  35. 35. Jia N, Chu W, Li Y, Ding L, Duan J, Cui J, et al. Iridoid glycosides from the flowers of Gentiana macrophylla Pall. ameliorate collagen-induced arthritis in rats. J Ethnopharmacol. 2016;189:1-9. doi:10.1016/j.jep.2016.05.027.
  36. 36. Qiang Gao, Haihui Qin, Lei Zhu, Dajin Li, Xiuwei Hao, Celastrol attenuates collagen-induced arthritis via inhibiting oxidative stress in rats. 10.1016/j.intimp.2020.106527
  37. 37. Magari K, Miyata S, Ohkubo Y, Mutoh S. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506. Inflammation Research. 2004;53:469–474.
  38. 38. Justin C. Earp, Debra C. DuBois, Diana S. Molano, Nancy A. Pyszczynski, Richard R. Almon, William J. Jusko Modeling Corticosteroid Effects in a Rat Model of Rheumatoid Arthritis II: Mechanistic Pharmacodynamic Model for Dexamethasone Effects in Lewis Rats with Collagen-Induced Arthritis.